Furthermore, it is well-known that the p14ARF/MDM2/TP53 pathway is one of the most important signaling pathways in cancer development, so we need to explore the potential role of this pathway in the progression of ESCC, which could provide novel insight into the treatment of ESCC. Here, MDM2 is linked to cancer.